Cingulate (NASDAQ:CING) PT Raised to $8.00 at HC Wainwright

Cingulate (NASDAQ:CING – Free Report) had its price objective boosted by HC Wainwright to $8.00 in a research note released on Friday morning, Benzinga reports. HC Wainwright currently has a buy rating on the stock. Several other analysts also recently commented on CING. Laidlaw downgraded shares of Cingulate from a buy rating to a hold […]

Related Keywords

,Maxim Group ,Hightower Advisors ,Cingulate Inc ,Geode Capital Management ,Renaissance Technologies ,Laidlaw ,Cingulate Company Profile ,Free Report ,Trading Down ,Get Free Report ,Capital Management ,Street Corp ,Tower Advisors ,Creative Planning ,Cingulate Daily ,Cingulate ,Nasdaq Cing ,Icing ,Medical ,Boost Price Target ,Hc Wainwright ,